XML 61 R47.htm IDEA: XBRL DOCUMENT v3.25.2
Acquisitions - Summary of Purchase Price Allocation (Details) - USD ($)
$ in Millions
 3 Months Ended
Jun. 30, 2025
Mar. 24, 2025
Jan. 16, 2025
Dec. 31, 2024
Disclosure of detailed information about business combination [line items]        
Measurement period adjustments, Net identifiable assets acquired $ 0      
Goodwill 9,181     $ 8,946
Aurion Biotech, Inc.        
Disclosure of detailed information about business combination [line items]        
Property, plant and equipment 3 $ 3    
Right-of-use assets 6 6    
Deferred tax assets 43 43    
Other current assets 6 6    
Cash and cash equivalents 26 26    
Non-current lease liabilities (4) (4)    
Non-current financial debts (1) (1)    
Deferred tax liabilities (212) (212)    
Current financial debts (34) (34)    
Current lease liabilities (2) (2)    
Current income tax liabilities (1) (1)    
Trade payables (3) (3)    
Provisions and other current liabilities (14) (14)    
Net identifiable assets acquired 743 743    
Goodwill 140 140    
Non-controlling interests (27) (27)    
Net assets acquired as a result of business combination 856 856    
Cash paid at closing 522 522    
Previously-held investment in associated company 334 334    
Total acquisition date fair value of consideration 856 856    
Total acquisition date fair value of consideration   486    
Aurion Biotech, Inc. | Current marketed products        
Disclosure of detailed information about business combination [line items]        
Intangible assets 110 105    
Measurement period adjustments, Intangible assets 5      
Aurion Biotech, Inc. | Acquired IPR&D        
Disclosure of detailed information about business combination [line items]        
Intangible assets 820 $ 825    
Measurement period adjustments, Intangible assets $ (5)      
Cylite Pty Ltd.        
Disclosure of detailed information about business combination [line items]        
Property, plant and equipment     $ 1  
Right-of-use assets     1  
Inventories     1  
Cash and cash equivalents     6  
Other assets     1  
Deferred tax liabilities     (11)  
Lease liabilities     (1)  
Trade payables     (1)  
Provisions and other current liabilities     (1)  
Net identifiable assets acquired     33  
Goodwill     90  
Net assets acquired as a result of business combination     123  
Cash paid at closing     78  
Cash expected to be paid after closing     2  
Previously-held FVOCI financial investment     11  
Previously-held commercialization rights in intangible assets     9  
Contingent consideration     9  
Previously-held investment in associated company     14  
Total acquisition date fair value of consideration     123  
Cylite Pty Ltd. | Current marketed products        
Disclosure of detailed information about business combination [line items]        
Intangible assets     4  
Cylite Pty Ltd. | Acquired IPR&D        
Disclosure of detailed information about business combination [line items]        
Intangible assets     $ 33